Seeing Is Believing
IONS is currently covered by 14 analysts with an average price target of $51.72. This is a potential upside of $10.13 (24.36%) from yesterday's end of day stock price of $41.59.
Ionis Pharmaceuticals's activity chart (see below) currently has 163 price targets and 161 ratings on display. The stock rating distribution of IONS is 68.18% BUY, 22.73% HOLD and 9.09% SELL.
Analysts average stock forecasts to be materialized ratio is 54.51% with an average time for these price targets to be met of 161.88 days.
Highest price target for IONS is $85, Lowest price target is $28, average price target is $51.72.
Most recent stock forecast was given by DO KIM from PIPER SANDLER on 22-Feb-2024. First documented stock forecast 12-Aug-2014.
Currently out of the existing stock ratings of IONS, 30 are a BUY (68.18%), 10 are a HOLD (22.73%), 4 are a SELL (9.09%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
63
$20.55 (48.41%)
62
2 months 4 days ago
11/24 (45.83%)
$19.02 (43.25%)
270
Buy
60
$17.55 (41.34%)
60
2 months 4 days ago
0/8 (0%)
$16.02 (36.43%)
Hold
55
$12.55 (29.56%)
41
2 months 25 days ago
2/3 (66.67%)
$4.03 (7.91%)
79
Buy
70
$27.55 (64.90%)
65
3 months ago
0/8 (0%)
$18.51 (35.95%)
Hold
48
$5.55 (13.07%)
27
3 months 4 days ago
7/12 (58.33%)
$-3.01 (-5.90%)
95
What is IONS (Ionis Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on IONS (Ionis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on IONS (Ionis Pharmaceuticals)?
Which analyst is the currently most bullish on IONS (Ionis Pharmaceuticals)?
Which analyst is the currently most reserved on IONS (Ionis Pharmaceuticals)?